Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.

Neuhauser M, Roetzer T, Oberndorfer S, Kitzwoegerer M, Payer F, Unterluggauer JJ, Haybaeck J, Stockhammer G, Iglseder S, Moser P, Thomé C, Stultschnig M, Wuertz F, Brandner-Kokalj T, Weis S, Bandke D, Pichler J, Hutterer M, Krenosz KJ, Boehm A, Mayrbaeurl B, Hager-Seifert A, Kaufmann H, Dumser M, Reiner-Concin A, Hoenigschnabl S, Kleindienst W, Hoffermann M, Dieckmann K, Kiesel B, Widhalm G, Marosi C, Jaeger U, Hainfellner A, Hackl M, Hainfellner JA, Preusser M, Woehrer A.

Acta Oncol. 2019 Jul;58(7):967-976. doi: 10.1080/0284186X.2019.1599137. Epub 2019 Apr 17.

PMID:
30994047
2.

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.

Buchroithner J, Erhart F, Pichler J, Widhalm G, Preusser M, Stockhammer G, Nowosielski M, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Hoffermann M, Ruckser R, Rössler K, Spiegl-Kreinecker S, Fischer MB, Czech T, Visus C, Krumpl G, Felzmann T, Marosi C.

Cancers (Basel). 2018 Oct 5;10(10). pii: E372. doi: 10.3390/cancers10100372.

3.

Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept.

Bräutigam E, Lampl C, Track C, Nieder C, Pichler J, Hammer J, Geinitz H.

Clin Transl Oncol. 2019 May;21(5):582-587. doi: 10.1007/s12094-018-1957-6. Epub 2018 Oct 3.

PMID:
30284233
4.

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.

Brandes AA, Gil-Gil M, Saran F, Carpentier AF, Nowak AK, Mason W, Zagonel V, Dubois F, Finocchiaro G, Fountzilas G, Cernea DM, Chinot O, Anghel R, Ghiringhelli F, Beauchesne P, Lombardi G, Franceschi E, Makrutzki M, Mpofu C, Urban HJ, Pichler J.

Oncologist. 2019 Apr;24(4):521-528. doi: 10.1634/theoncologist.2018-0290. Epub 2018 Sep 28.

PMID:
30266892
5.

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease.

Schneider AM, Weghuber D, Hetzer B, Entenmann A, Müller T, Zimmermann G, Schütz S, Huber WD, Pichler J.

BMC Gastroenterol. 2018 Sep 15;18(1):140. doi: 10.1186/s12876-018-0868-x.

6.

TLR9-mediated activation of dendritic cells by CD32 targeting for the generation of highly immunostimulatory vaccines.

Sepulveda-Toepfer JA, Pichler J, Fink K, Sevo M, Wildburger S, Mudde-Boer LC, Taus C, Mudde GC.

Hum Vaccin Immunother. 2019;15(1):179-188. doi: 10.1080/21645515.2018.1514223. Epub 2018 Sep 19.

7.

The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.

Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning KH, Furtner J, Sheffield NC, Datlinger P, Peter N, Nowosielski M, Augustin M, Mischkulnig M, Ströbel T, Alpar D, Ergüner B, Senekowitsch M, Moser P, Freyschlag CF, Kerschbaumer J, Thomé C, Grams AE, Stockhammer G, Kitzwoegerer M, Oberndorfer S, Marhold F, Weis S, Trenkler J, Buchroithner J, Pichler J, Haybaeck J, Krassnig S, Mahdy Ali K, von Campe G, Payer F, Sherif C, Preiser J, Hauser T, Winkler PA, Kleindienst W, Würtz F, Brandner-Kokalj T, Stultschnig M, Schweiger S, Dieckmann K, Preusser M, Langs G, Baumann B, Knosp E, Widhalm G, Marosi C, Hainfellner JA, Woehrer A, Bock C.

Nat Med. 2018 Oct;24(10):1611-1624. doi: 10.1038/s41591-018-0156-x. Epub 2018 Aug 27.

8.

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.

Spiegl-Kreinecker S, Lötsch D, Neumayer K, Kastler L, Gojo J, Pirker C, Pichler J, Weis S, Kumar R, Webersinke G, Gruber A, Berger W.

Neuro Oncol. 2018 Nov 12;20(12):1584-1593. doi: 10.1093/neuonc/noy104.

9.

Assessment of endothelial cell function and physiological microcirculatory reserve by video microscopy using a topical acetylcholine and nitroglycerin challenge.

Hilty MP, Pichler J, Ergin B, Hefti U, Merz TM, Ince C, Maggiorini M.

Intensive Care Med Exp. 2017 Dec;5(1):26. doi: 10.1186/s40635-017-0139-0. Epub 2017 May 18.

10.

Chylothorax in thyroid surgery: a very rare case and systematic review of the literature.

Merki V, Pichler J, Giger R, Mantokoudis G.

J Otolaryngol Head Neck Surg. 2016 Oct 18;45(1):52. Review.

11.

Reduced risk of pulmonary emboli in children treated with long-term parenteral nutrition.

Pichler J, Biassoni L, Easty M, Irastorza I, Hill S.

Clin Nutr. 2016 Dec;35(6):1406-1413. doi: 10.1016/j.clnu.2016.03.016. Epub 2016 Mar 31.

PMID:
27086197
12.

Histopathological features of gastrointestinal mucosal biopsies in children with juvenile idiopathic arthritis.

Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, Pilkington C, Elawad M.

Pediatr Res. 2016 Jun;79(6):895-901. doi: 10.1038/pr.2016.27. Epub 2016 Feb 16.

PMID:
26882369
13.

Microarray profiling of preselected CHO host cell subclones identifies gene expression patterns associated with increased production capacity.

Harreither E, Hackl M, Pichler J, Shridhar S, Auer N, Łabaj PP, Scheideler M, Karbiener M, Grillari J, Kreil DP, Borth N.

Biotechnol J. 2015 Oct;10(10):1625-38. doi: 10.1002/biot.201400857. Epub 2015 Sep 23.

PMID:
26315449
14.

Overexpression of Hsp70 confers cytoprotection during gliadin exposure in Caco-2 cells.

Bidmon-Fliegenschnee B, Lederhuber HCh, Csaicsich D, Pichler J, Herzog R, Memaran-Dadgar N, Huber WD, Aufricht C, Kratochwill K.

Pediatr Res. 2015 Oct;78(4):358-64. doi: 10.1038/pr.2015.112. Epub 2015 Jun 18.

PMID:
26086640
15.

Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody.

Pichler J, Huber WD, Aufricht C, Bidmon-Fliegenschnee B.

World J Gastroenterol. 2015 Jun 7;21(21):6613-20. doi: 10.3748/wjg.v21.i21.6613.

16.

Nutritional status in children with Shwachman-diamond syndrome.

Pichler J, Meyer R, Köglmeier J, Ancliff P, Shah N.

Pancreas. 2015 May;44(4):590-5. doi: 10.1097/MPA.0000000000000291.

PMID:
25742431
17.

Prevalence of Gallstones Compared in Children With Different Intravenous Lipids.

Pichler J, Watson T, McHugh K, Hill S.

J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):253-9. doi: 10.1097/MPG.0000000000000761.

PMID:
25688480
18.

Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.

Spiegl-Kreinecker S, Lötsch D, Ghanim B, Pirker C, Mohr T, Laaber M, Weis S, Olschowski A, Webersinke G, Pichler J, Berger W.

Neuro Oncol. 2015 Sep;17(9):1231-40. doi: 10.1093/neuonc/nov010. Epub 2015 Feb 13.

19.

MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial.

Weller M, Tabatabai G, Kästner B, Felsberg J, Steinbach JP, Wick A, Schnell O, Hau P, Herrlinger U, Sabel MC, Wirsching HG, Ketter R, Bähr O, Platten M, Tonn JC, Schlegel U, Marosi C, Goldbrunner R, Stupp R, Homicsko K, Pichler J, Nikkhah G, Meixensberger J, Vajkoczy P, Kollias S, Hüsing J, Reifenberger G, Wick W; DIRECTOR Study Group.

Clin Cancer Res. 2015 May 1;21(9):2057-64. doi: 10.1158/1078-0432.CCR-14-2737. Epub 2015 Feb 5.

20.

A phase II, randomized, study of weekly APG101+reirradiation versus reirradiation in progressive glioblastoma.

Wick W, Fricke H, Junge K, Kobyakov G, Martens T, Heese O, Wiestler B, Schliesser MG, von Deimling A, Pichler J, Vetlova E, Harting I, Debus J, Hartmann C, Kunz C, Platten M, Bendszus M, Combs SE.

Clin Cancer Res. 2014 Dec 15;20(24):6304-13. doi: 10.1158/1078-0432.CCR-14-0951-T. Epub 2014 Oct 22.

21.

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.

Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Pichler J, Hutterer M, Melchardt T, Bartsch R, Zielinski CC, Birner P, Preusser M.

Neuropathol Appl Neurobiol. 2015 Feb;41(2):e41-55. doi: 10.1111/nan.12185.

PMID:
25256708
22.

The Shampoo pH can Affect the Hair: Myth or Reality?

Gavazzoni Dias MF, de Almeida AM, Cecato PM, Adriano AR, Pichler J.

Int J Trichology. 2014 Jul;6(3):95-9. doi: 10.4103/0974-7753.139078.

23.

Comparison of liver function with two new/mixed intravenous lipid emulsions in children with intestinal failure.

Pichler J, Simchowitz V, Macdonald S, Hill S.

Eur J Clin Nutr. 2014 Oct;68(10):1161-7. doi: 10.1038/ejcn.2014.118. Epub 2014 Jun 25.

PMID:
24961544
24.

Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?

Brandes AA, Mason W, Pichler J, Nowak AK, Gil M, Saran F, Revil C, Lutiger B, Carpentier AF.

Future Oncol. 2014 May;10(7):1137-45. doi: 10.2217/fon.14.75.

PMID:
24947255
25.

Prevalence of undernutrition during hospitalisation in a children's hospital: what happens during admission?

Pichler J, Hill SM, Shaw V, Lucas A.

Eur J Clin Nutr. 2014 Jun;68(6):730-5. doi: 10.1038/ejcn.2014.21. Epub 2014 Mar 12.

PMID:
24619108
26.

Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.

Drummond A, Pichler J, Argenziano G, Zalaudek I, Longo C, Lallas A, Piana S, Moscarella E.

Australas J Dermatol. 2015 Nov;56(4):e105-7. doi: 10.1111/ajd.12151. Epub 2014 Feb 13.

PMID:
24575881
27.

Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.

Buchroithner J, Pichler J, Marosi C, Widhalm G, Seiz-Rosenhagen M, Novosielski M, Oberndorfer S, Ruckser R, Rössler K, Azizi A, von Campe G, Bordihn K, Felzmann T.

Int J Clin Pharmacol Ther. 2014 Jan;52(1):76-7. doi: 10.5414/CPXCES13EA02. No abstract available.

PMID:
24321210
28.

Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.

Woehrer A, Hackl M, Waldhör T, Weis S, Pichler J, Olschowski A, Buchroithner J, Maier H, Stockhammer G, Thomé C, Haybaeck J, Payer F, von Campe G, Kiefer A, Würtz F, Vince GH, Sedivy R, Oberndorfer S, Marhold F, Bordihn K, Stiglbauer W, Gruber-Mösenbacher U, Bauer R, Feichtinger J, Reiner-Concin A, Grisold W, Marosi C, Preusser M, Dieckmann K, Slavc I, Gatterbauer B, Widhalm G, Haberler C, Hainfellner JA; Austrian Brain Tumour Registry.

Br J Cancer. 2014 Jan 21;110(2):286-96. doi: 10.1038/bjc.2013.714. Epub 2013 Nov 19.

29.

Paediatric patients with inflammatory bowel disease who received infliximab experienced improved growth and bone health.

Pichler J, Hanslik A, Huber WD, Aufricht C, Bidmon-Fliegenschnee B.

Acta Paediatr. 2014 Feb;103(2):e69-75. doi: 10.1111/apa.12448. Epub 2013 Nov 15.

PMID:
24237381
30.

Body composition in paediatric intestinal failure patients receiving long-term parenteral nutrition.

Pichler J, Chomtho S, Fewtrell M, Macdonald S, Hill S.

Arch Dis Child. 2014 Feb;99(2):147-53. doi: 10.1136/archdischild-2012-303516. Epub 2013 Oct 28.

PMID:
24167070
31.

Reduction of blood stream infections in children following a change to chlorhexidine disinfection of parenteral nutrition catheter connectors.

Pichler J, Soothill J, Hill S.

Clin Nutr. 2014 Feb;33(1):85-9. doi: 10.1016/j.clnu.2013.03.021. Epub 2013 Apr 10.

PMID:
23623781
32.

Growth and bone health in pediatric intestinal failure patients receiving long-term parenteral nutrition.

Pichler J, Chomtho S, Fewtrell M, Macdonald S, Hill SM.

Am J Clin Nutr. 2013 Jun;97(6):1260-9. doi: 10.3945/ajcn.112.057935. Epub 2013 Apr 10.

PMID:
23576042
33.

Cognitive performance in high-altitude climbers: a comparative study of saccadic eye movements and neuropsychological tests.

Merz TM, Bosch MM, Barthelmes D, Pichler J, Hefti U, Schmitt KU, Bloch KE, Schoch OD, Hess T, Turk AJ, Schwarz U.

Eur J Appl Physiol. 2013 Aug;113(8):2025-37. doi: 10.1007/s00421-013-2635-6. Epub 2013 Apr 6.

PMID:
23563571
34.

MRI assessment of relapsed glioblastoma during treatment with bevacizumab: volumetric measurement of enhanced and FLAIR lesions for evaluation of response and progression--a pilot study.

Pichler J, Pachinger C, Pelz M, Kleiser R.

Eur J Radiol. 2013 May;82(5):e240-5. doi: 10.1016/j.ejrad.2012.12.018. Epub 2013 Feb 9.

PMID:
23399039
35.

Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.

Lötsch D, Ghanim B, Laaber M, Wurm G, Weis S, Lenz S, Webersinke G, Pichler J, Berger W, Spiegl-Kreinecker S.

Neuro Oncol. 2013 Apr;15(4):423-32. doi: 10.1093/neuonc/nos329. Epub 2013 Feb 7.

36.

Clinical neuropathology practice guide 1-2013: molecular subtyping of glioblastoma: ready for clinical use?

Woehrer A, Marosi C, Widhalm G, Oberndorfer S, Pichler J, Hainfellner JA.

Clin Neuropathol. 2013 Jan-Feb;32(1):5-8.

37.

Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO).

Leibetseder A, Ackerl M, Flechl B, Wöhrer A, Widhalm G, Dieckmann K, Kreinecker SS, Pichler J, Hainfellner J, Preusser M, Marosi C.

Neuro Oncol. 2013 Jan;15(1):112-21. doi: 10.1093/neuonc/nos283. Epub 2012 Dec 7.

38.

Extent of peritumoral brain edema correlates with prognosis, tumoral growth pattern, HIF1a expression and angiogenic activity in patients with single brain metastases.

Spanberger T, Berghoff AS, Dinhof C, Ilhan-Mutlu A, Magerle M, Hutterer M, Pichler J, Wöhrer A, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M.

Clin Exp Metastasis. 2013 Apr;30(4):357-68. doi: 10.1007/s10585-012-9542-9. Epub 2012 Oct 17.

PMID:
23076770
39.

Robust multi-parameter single-platform quantification of myeloid and B-lymphoid CD34 progenitor cells in all clinical CD34 cell sources and in thawed PBSC.

Fritsch G, Witt V, Spengler HP, Pichler J, Scharner D, Zipperer E, Trbojevic D, Stemberger J, Geyeregger R, Tea MK, Printz D.

Pediatr Hematol Oncol. 2012 Oct;29(7):595-610. Epub 2012 Sep 6.

PMID:
22954345
40.

Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.

Bishay M, Pichler J, Horn V, Macdonald S, Ellmer M, Eaton S, Hill S, Pierro A.

J Pediatr Surg. 2012 Feb;47(2):359-62. doi: 10.1016/j.jpedsurg.2011.11.032.

PMID:
22325390
41.

Intestinal failure-associated liver disease in hospitalised children.

Pichler J, Horn V, Macdonald S, Hill S.

Arch Dis Child. 2012 Mar;97(3):211-4. doi: 10.1136/archdischild-2011-300274. Epub 2012 Jan 13.

PMID:
22247247
42.

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.

Capper D, Berghoff AS, Magerle M, Ilhan A, Wöhrer A, Hackl M, Pichler J, Pusch S, Meyer J, Habel A, Petzelbauer P, Birner P, von Deimling A, Preusser M.

Acta Neuropathol. 2012 Feb;123(2):223-33. doi: 10.1007/s00401-011-0887-y. Epub 2011 Oct 20.

PMID:
22012135
43.

Feasibility of a finger prick-based self-testing kit in first- and second-degree relatives of children with coeliac disease.

Pichler J, Zilbauer M, Torrente F, Heuschkel R, Phillips A, Salvestrini C.

World J Gastroenterol. 2011 Apr 14;17(14):1840-3. doi: 10.3748/wjg.v17.i14.1840.

44.

Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials.

Hofer S, Elandt K, Greil R, Hottinger AF, Huber U, Lemke D, Marosi C, Ochsenbein A, Pichler J, Roelcke U, Weder P, Zander T, Wick W, Weller M.

Acta Oncol. 2011 Jun;50(5):630-5. doi: 10.3109/0284186X.2011.572913. Epub 2011 Apr 18.

PMID:
21495907
45.

[Drug therapy of patients with recurrent glioblastoma: is there any evidence?].

Pichler J, Marosi C.

Wien Med Wochenschr. 2011 Jan;161(1-2):26-31. doi: 10.1007/s10354-010-0863-5. Epub 2010 Dec 27. Review. German.

PMID:
21181283
46.

Selection of CHO host cell subclones with increased specific antibody production rates by repeated cycles of transient transfection and cell sorting.

Pichler J, Galosy S, Mott J, Borth N.

Biotechnol Bioeng. 2011 Feb;108(2):386-94. doi: 10.1002/bit.22946.

PMID:
20842656
47.

Update: Multinational listeriosis outbreak due to 'Quargel', a sour milk curd cheese, caused by two different L. monocytogenes serotype 1/2a strains, 2009-2010.

Fretz R, Pichler J, Sagel U, Much P, Ruppitsch W, Pietzka AT, Stöger A, Huhulescu S, Heuberger S, Appl G, Werber D, Stark K, Prager R, Flieger A, Karpísková R, Pfaff G, Allerberger F.

Euro Surveill. 2010 Apr 22;15(16). pii: 19543.

48.

Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance?

Pichler R, Dunzinger A, Wurm G, Pichler J, Weis S, Nussbaumer K, Topakian R, Aigner RM.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1521-8. doi: 10.1007/s00259-010-1457-6. Epub 2010 Apr 16.

PMID:
20396883
49.

Sepsis and its etiology among hospitalized children less than 1 year of age with intestinal failure on parenteral nutrition.

Pichler J, Horn V, Macdonald S, Hill S.

Transplant Proc. 2010 Jan-Feb;42(1):24-5. doi: 10.1016/j.transproceed.2009.12.011.

PMID:
20172274
50.

Review of the diagnoses predisposing infants to intestinal failure on hospitalized parenteral nutrition.

Pichler J, Horn V, Macdonald S, Hill S.

Transplant Proc. 2010 Jan-Feb;42(1):22-3. doi: 10.1016/j.transproceed.2009.12.012.

PMID:
20172273

Supplemental Content

Loading ...
Support Center